Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5909175 | 0.97 | MEN1 (0.52) | MEN1KMT2ARXFP1FAAHMAPK1 | |
| SCHEMBL3313335 | 0.94 | MEN1 (0.50) | MEN1KMT2ARXFP1FAAHMAPK1 | |
| SCHEMBL11996854 | 0.86 | RXFP1 (0.46) | MEN1KMT2ARXFP1FAAHMAPK1 | |
| SCHEMBL21617351 | 0.84 | RXFP1 (0.44) | MEN1KMT2ARXFP1FAAHMAPK1 | |
| SCHEMBL9911495 | 0.82 | MEN1 (0.46) | MEN1KMT2ARXFP1FAAHMAPK1 | |
| SCHEMBL2417430 | 0.82 | MEN1 (0.46) | MEN1KMT2ARXFP1FAAHMAPK1 | |
| SCHEMBL13884540 | 0.82 | MEN1 (0.47) | MEN1KMT2ARXFP1FAAHMAPK1 | |
| SCHEMBL5909062 | 0.81 | MEN1 (0.62) | MEN1KMT2ARXFP1FAAHMAPK1 | |
| SCHEMBL21394036 | 0.80 | MEN1 (0.45) | MEN1KMT2ARXFP1FAAHMAPK1 | |
| SCHEMBL8909886 | 0.80 | MEN1 (0.45) | MEN1KMT2ARXFP1FAAHMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9373677-B2 | Doping of ZrO2 for DRAM applications | ENTEGRIS, INC. (US) | 2016-06-21 | — | — | US | claimed |
| US-20130122722-A1 | DOPING OF ZrO2 FOR DRAM APPLICATIONS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2013-05-16 | — | — | US | claimed |
| WO-2012005957-A2 | DOPING OF ZRO2 FOR DRAM APPLICATIONS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2012-01-12 | — | — | WO | claimed |
| US-12410202-B2 | Group V and VI transition metal precursors for thin film deposition | VERSUM MATERIALS US, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-20220315612-A1 | NEW GROUP V AND VI TRANSITION METAL PRECURSORS FOR THIN FILM DEPOSITION | VERSUM MATERIALS US, LLC (US) | 2022-10-06 | — | — | US | disclosed |
| EP-3976852-A1 | NEW GROUP V AND VI TRANSITION METAL PRECURSORS FOR THIN FILM DEPOSITION | Versum Materials US, LLC (US) | 2022-04-06 | — | — | EP | disclosed |
| WO-2020247237-A1 | NEW GROUP V AND VI TRANSITION METAL PRECURSORS FOR THIN FILM DEPOSITION | VERSUM MATERIALS US, LLC (US) | 2020-12-10 | — | — | WO | disclosed |
| US-20160343795-A1 | DOPING OF ZrO2 FOR DRAM APPLICATIONS | ENTEGRIS, INC. (US) | 2016-11-24 | — | — | US | disclosed |
| US-20160343795-A1 | DOPING OF ZrO2 FOR DRAM APPLICATIONS | ENTEGRIS, INC. (US) | 2016-11-24 | — | — | US | disclosed |
| US-9373677-B2 | Doping of ZrO2 for DRAM applications | ENTEGRIS, INC. (US) | 2016-06-21 | — | — | US | disclosed |
| US-9373677-B2 | Doping of ZrO2 for DRAM applications | ENTEGRIS, INC. (US) | 2016-06-21 | — | — | US | disclosed |
| US-20130122722-A1 | DOPING OF ZrO2 FOR DRAM APPLICATIONS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130122722-A1 | DOPING OF ZrO2 FOR DRAM APPLICATIONS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2013-05-16 | — | — | US | disclosed |
| WO-2012005957-A3 | DOPING OF ZRO2 FOR DRAM APPLICATIONS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2012-04-12 | — | — | WO | disclosed |
| WO-2012005957-A2 | DOPING OF ZRO2 FOR DRAM APPLICATIONS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2012-01-12 | — | — | WO | disclosed |
| WO-2012005957-A2 | DOPING OF ZRO2 FOR DRAM APPLICATIONS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2012-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220315612-A1 | NEW GROUP V AND VI TRANSITION METAL PRECURSORS FOR THIN FILM DEPOSITION | VAPA, IGLV6-57, VDAC1 | MEN1 3097/4885KMT2A 1111/4885RXFP1 4840/4885 |
| US-12410202-B2 | Group V and VI transition metal precursors for thin film deposition | IGLV6-57, CDV3, ITGAV | MEN1 3090/4885KMT2A 1101/4885RXFP1 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.